Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "Working-Capital-Turnover" stands at 9.84 as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Working Capital Turnover" stands at 9.84. This represents a decrease of -7.68 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.94 percent compared to the value the year prior.
The 1 year change in percent is -7.94.
The 3 year change in percent is 21.58.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Working Capital Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Working Capital Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Working Capital Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Working Capital Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Working Capital Turnover | 280,205,508,085.11 |